Brief: Repare Therapeutics Provides Corporate Update And Highlights Anticipated Key 2024 Milestones
08/01/2024 13:22
Jan 8 (Reuters) - Repare Therapeutics Inc RPTX.O :
* REPARE THERAPEUTICS PROVIDES CORPORATE UPDATE AND
HIGHLIGHTS
ANTICIPATED KEY 2024 MILESTONES
* REPARE THERAPEUTICS - ENDED 2023 WITH ABOUT $223 MILLION
IN
CASH, CASH EQUIVALENTS & MARKETABLE SECURITIES, THAT IS EXPECTED
TO FUND PLANNED OPERATIONS INTO MID-2026
Source text for Eikon: ID:nBw4mfqd6a
Further company coverage: RPTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Repare Therapeutics
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Repare Therapeutics Announces Acquisition Of Polθ ATPase Inhibitor, RP-3467, By Gilead Sciences For Up To $30 Million In Total Consideration
Brief: Repare Signs Support Agreements With Key Shareholders For Xenotherapeutics Deal
Repare Therapeutics Q2 net loss narrows to $16.7 mln